Product NDC: | 68258-3042 |
Proprietary Name: | ENGERIX-B |
Non Proprietary Name: | Hepatitis B Vaccine (Recombinant) |
Active Ingredient(s): | 20 ug/mL & nbsp; Hepatitis B Vaccine (Recombinant) |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68258-3042 |
Labeler Name: | Dispensing Solutions Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103239 |
Marketing Category: | BLA |
Start Marketing Date: | 20090528 |
Package NDC: | 68258-3042-1 |
Package Description: | 1 VIAL in 1 CARTON (68258-3042-1) > 1 mL in 1 VIAL |
NDC Code | 68258-3042-1 |
Proprietary Name | ENGERIX-B |
Package Description | 1 VIAL in 1 CARTON (68258-3042-1) > 1 mL in 1 VIAL |
Product NDC | 68258-3042 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hepatitis B Vaccine (Recombinant) |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20090528 |
Marketing Category Name | BLA |
Labeler Name | Dispensing Solutions Inc. |
Substance Name | HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
Strength Number | 20 |
Strength Unit | ug/mL |
Pharmaceutical Classes |